Clinical Trial Update: Safety and Efficacy of Low-Dose Ticagrelor in Chinese Patients With NSTE-ACS [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating the safety and efficacy of low-dose ticagrelor in Chinese patients with non-ST elevation acute coronary syndrome. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-elevation Acute Coronary Syndrome

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: First Affiliated Hospital of Harbin Medical University | Conditions: Non ST Segment Elevation Acute Coronary Syndrome | Phase 3 | Status: UNKNOWN